AstraZeneca Stays Hopeful About Ultomiris Despite Initial Conversion Difficulties

Sales of Soliris Successor Stumble

Finger pressing light switch button.
AstraZeneca Wants Patients To Switch From Soliris To Ultomiris • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip